Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma

Christina L. Roland, Caitlin D. May, Kelsey L. Watson, Ghadah A. Al Sannaa, Sean P. Dineen, Rachel Feig, Sharon Landers, Davis R. Ingram, Wei Lien Wang, B. Ashleigh Guadagnolo, Barry Feig, Kelly K. Hunt, Janice N. Cormier, A. J. Lazar, Keila E. Torres

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Undifferentiated pleomorphic sarcomas (UPS) present a diagnostic and therapeutic challenge. Identification of prognostic molecular markers is required for the discovery of novel treatment approaches. The purpose of this study was to correlate clinicopathologic variables, expression of tyrosine kinase receptors, and markers of cell cycle progression and survival with oncologic outcomes.Methods: A tissue microarray containing 208 primary UPS samples was analyzed by immunohistochemistry for protein markers and in situ hybridization for microRNA. Staining results were correlated with clinicopathologic features and oncologic outcomes. Univariate and multivariate analyses were conducted to assess associations between expression of protein markers, mi-RNA, and outcome.Results: At a median follow-up of 3.9 years (9 years for survivors), 5-year disease-specific survival (DSS) was 63 %. Clinical variables associated with improved DSS included age

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalAnnals of Surgical Oncology
DOIs
StateAccepted/In press - Feb 3 2016

Fingerprint

Sarcoma
Receptor Protein-Tyrosine Kinases
MicroRNAs
In Situ Hybridization
Cell Survival
Cell Cycle
Proteins
Multivariate Analysis
Immunohistochemistry
RNA
Staining and Labeling
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Roland, C. L., May, C. D., Watson, K. L., Al Sannaa, G. A., Dineen, S. P., Feig, R., ... Torres, K. E. (Accepted/In press). Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Annals of Surgical Oncology, 1-9. https://doi.org/10.1245/s10434-016-5115-5

Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. / Roland, Christina L.; May, Caitlin D.; Watson, Kelsey L.; Al Sannaa, Ghadah A.; Dineen, Sean P.; Feig, Rachel; Landers, Sharon; Ingram, Davis R.; Wang, Wei Lien; Ashleigh Guadagnolo, B.; Feig, Barry; Hunt, Kelly K.; Cormier, Janice N.; Lazar, A. J.; Torres, Keila E.

In: Annals of Surgical Oncology, 03.02.2016, p. 1-9.

Research output: Contribution to journalArticle

Roland, CL, May, CD, Watson, KL, Al Sannaa, GA, Dineen, SP, Feig, R, Landers, S, Ingram, DR, Wang, WL, Ashleigh Guadagnolo, B, Feig, B, Hunt, KK, Cormier, JN, Lazar, AJ & Torres, KE 2016, 'Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma', Annals of Surgical Oncology, pp. 1-9. https://doi.org/10.1245/s10434-016-5115-5
Roland, Christina L. ; May, Caitlin D. ; Watson, Kelsey L. ; Al Sannaa, Ghadah A. ; Dineen, Sean P. ; Feig, Rachel ; Landers, Sharon ; Ingram, Davis R. ; Wang, Wei Lien ; Ashleigh Guadagnolo, B. ; Feig, Barry ; Hunt, Kelly K. ; Cormier, Janice N. ; Lazar, A. J. ; Torres, Keila E. / Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. In: Annals of Surgical Oncology. 2016 ; pp. 1-9.
@article{ab20be4b2d424b98bc3b35473d6323f0,
title = "Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma",
abstract = "Background: Undifferentiated pleomorphic sarcomas (UPS) present a diagnostic and therapeutic challenge. Identification of prognostic molecular markers is required for the discovery of novel treatment approaches. The purpose of this study was to correlate clinicopathologic variables, expression of tyrosine kinase receptors, and markers of cell cycle progression and survival with oncologic outcomes.Methods: A tissue microarray containing 208 primary UPS samples was analyzed by immunohistochemistry for protein markers and in situ hybridization for microRNA. Staining results were correlated with clinicopathologic features and oncologic outcomes. Univariate and multivariate analyses were conducted to assess associations between expression of protein markers, mi-RNA, and outcome.Results: At a median follow-up of 3.9 years (9 years for survivors), 5-year disease-specific survival (DSS) was 63 {\%}. Clinical variables associated with improved DSS included age",
author = "Roland, {Christina L.} and May, {Caitlin D.} and Watson, {Kelsey L.} and {Al Sannaa}, {Ghadah A.} and Dineen, {Sean P.} and Rachel Feig and Sharon Landers and Ingram, {Davis R.} and Wang, {Wei Lien} and {Ashleigh Guadagnolo}, B. and Barry Feig and Hunt, {Kelly K.} and Cormier, {Janice N.} and Lazar, {A. J.} and Torres, {Keila E.}",
year = "2016",
month = "2",
day = "3",
doi = "10.1245/s10434-016-5115-5",
language = "English (US)",
pages = "1--9",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",

}

TY - JOUR

T1 - Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma

AU - Roland, Christina L.

AU - May, Caitlin D.

AU - Watson, Kelsey L.

AU - Al Sannaa, Ghadah A.

AU - Dineen, Sean P.

AU - Feig, Rachel

AU - Landers, Sharon

AU - Ingram, Davis R.

AU - Wang, Wei Lien

AU - Ashleigh Guadagnolo, B.

AU - Feig, Barry

AU - Hunt, Kelly K.

AU - Cormier, Janice N.

AU - Lazar, A. J.

AU - Torres, Keila E.

PY - 2016/2/3

Y1 - 2016/2/3

N2 - Background: Undifferentiated pleomorphic sarcomas (UPS) present a diagnostic and therapeutic challenge. Identification of prognostic molecular markers is required for the discovery of novel treatment approaches. The purpose of this study was to correlate clinicopathologic variables, expression of tyrosine kinase receptors, and markers of cell cycle progression and survival with oncologic outcomes.Methods: A tissue microarray containing 208 primary UPS samples was analyzed by immunohistochemistry for protein markers and in situ hybridization for microRNA. Staining results were correlated with clinicopathologic features and oncologic outcomes. Univariate and multivariate analyses were conducted to assess associations between expression of protein markers, mi-RNA, and outcome.Results: At a median follow-up of 3.9 years (9 years for survivors), 5-year disease-specific survival (DSS) was 63 %. Clinical variables associated with improved DSS included age

AB - Background: Undifferentiated pleomorphic sarcomas (UPS) present a diagnostic and therapeutic challenge. Identification of prognostic molecular markers is required for the discovery of novel treatment approaches. The purpose of this study was to correlate clinicopathologic variables, expression of tyrosine kinase receptors, and markers of cell cycle progression and survival with oncologic outcomes.Methods: A tissue microarray containing 208 primary UPS samples was analyzed by immunohistochemistry for protein markers and in situ hybridization for microRNA. Staining results were correlated with clinicopathologic features and oncologic outcomes. Univariate and multivariate analyses were conducted to assess associations between expression of protein markers, mi-RNA, and outcome.Results: At a median follow-up of 3.9 years (9 years for survivors), 5-year disease-specific survival (DSS) was 63 %. Clinical variables associated with improved DSS included age

UR - http://www.scopus.com/inward/record.url?scp=84957582202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957582202&partnerID=8YFLogxK

U2 - 10.1245/s10434-016-5115-5

DO - 10.1245/s10434-016-5115-5

M3 - Article

SP - 1

EP - 9

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -